Impact of coronary artery calcification in hemodialysis patients: Risk factors and associations with prognosis

Hemodialysis International

Volumn 14, Issue 2, 2010, Pages 218-225

  Ohtake, Takayasu ^a   Ishioka, Kunihiro ^a   Honda, Kenjiro ^a   Oka, Machiko ^a   Maesato, Kyoko ^a   Mano, Tsutomu ^a   Ikee, Ryota ^a   Moriya, Hidekazu ^a   Hidaka, Sumi ^a   Kobayashi, Shuzo ^a  

^a SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

Author keywords

Cardiovascular events; Coronary artery calcification; Hemodialysis; HsCRP; Inflammation

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; FIBRINOGEN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DISEASE COURSE; ELECTRON BEAM TOMOGRAPHY; FEMALE; HEART DEATH; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; AGED; BIOLOGICAL MODEL; BLOOD; CALCINOSIS; CHRONIC KIDNEY FAILURE; COMPUTER ASSISTED TOMOGRAPHY; KAPLAN MEIER METHOD; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; PREVALENCE; RADIOGRAPHY; REGRESSION ANALYSIS; RENAL REPLACEMENT THERAPY; STATISTICS; VASCULITIS;

AGED; C-REACTIVE PROTEIN; CALCINOSIS; CALCIUM; COHORT STUDIES; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FIBRINOGEN; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RENAL DIALYSIS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VASCULITIS;

EID: 77956416281     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2009.00423.x     Document Type: Article

References (19)

1. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events. J Am Coll Cardiol 2005, 46:158-165.
2. Matsuoka M, Iseki K, Tamashiro M. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004, 8:54-58.
3. Block GA, Raggi P, Bellasi A. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007, 71:438-441.
4. Brancaccio D, Tetta C, Gallieni M, Panichi V. Inflammation, CRP, calcium overload and a high calcium-phosphate product: A "liaison dangereuse." Nephrol Dial Transplant 2002, 17:201-203.
5. Moe SM, Reslerova M, Ketteler M. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 2005, 67:2295-2304.
6. Ketteler M, Bongartz P, Westenfeld R. Association of low fetuin-A (AHSG) concentration in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet 2003, 361:827-833.
7. Ding HT, Wang CG, Zhang TL, Wang K. Fibronectin enhances in vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells via ERK pathway. J Cell Biochem 2006, 99:1343-1352.
8. Stomper T, Pasowicz M, Sullowicz W. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 2003, 41:203-211.
9. Jung HH, Kim SW, Han H. Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrol Dial Transplant 2006, 21:1915-1920.
10. Agatston AS, Janowitz WR, Hildner F. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15:827-832.
11. Bonora E, Targher G, Alberiche M. Homeostatic model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000, 23:57-63.
12. Kobayashi S, Moriya H, Aso K, Ohtake T. Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells. Kidney Int 2003, 63:1881-1887.
13. Ohtake T, Kobayashi S, Moriya H. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: An angiographic examination. J Am Soc Nephrol 2005, 16:1141-1148.
14. Kowalewski R, Towler DA, Martin KJ. TNF-α regulates the sodium-phosphate cotransporter Pit-1: Evidence that links inflammation to vascular calcification. J Am Soc Nephrol 2006, 17:103A. (abstract)
15. Vernaglione L, Cristofano C, Muscogiuri P, Chimienti S. Does atorvastatin influence serum C-reative protein levels in patients on long-term hemodialysis? Am J Kidney Dis 2004, 43:471-478.
16. Ichihara A, Hayashi M, Ryuzaki M. Fluvastatin prevents development of arterial stiffness in hemodailysis patients with type 2 diabetes mellitus. Nephrol Dial Transplant 2002, 17:1513-1517.
17. Chang JW, Yang WS, Min WK. Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients. Am J Kidney Dis 2002, 39:1213-1217.
18. Yamada K, Fujimoto S, Tokura T. Effect of sevelamer on dyslipidemia and chronic inflammation in maintenance hemodialysis patients. Ren Fail 2005, 27:361-365.
19. Furuya R, Kumagai H, Takahashi M. Ultrapure dialysate reduces plasma levels of beta 2-microglobulin and pentosidine in hemodialysis patients. Blood Purif 2005, 23:311-316.